Clinical outcomes with biodegradable versus durable polymer drug-eluting stents in patients with ST-elevation myocardial infarction.
Gustavo Neves de AraujoGuilherme Pinheiro MachadoMarcia MouraAnderson Donelli SilveiraLuiz Carlos BergoliFelipe Costa FuchsRodrigo Vugman WainsteinSandro Cadaval GoncalvesPedro A LemosAlexandre Schaan de QuadrosMarco Vugman WainsteinPublished in: Cardiovascular revascularization medicine : including molecular interventions (2024)
In a cohort of STEMI patients submitted to pPCI, BP and DP DES had similar rates of the primary outcome. Patients treated with BP DES, however, had a decreased incidence of TLR at after 2-year follow-up.
Keyphrases
- st elevation myocardial infarction
- percutaneous coronary intervention
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- drug delivery
- immune response
- prognostic factors
- risk factors
- emergency department
- st segment elevation myocardial infarction
- toll like receptor
- coronary artery disease
- acute coronary syndrome
- patient reported outcomes
- adverse drug